Actavis Pharma Development Centre Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 13.02 Cr
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
- Satisfied Charges ₹ 24.85 Cr
- Revenue Growth 2.48%
- Profit Growth 36.54%
- Ebitda 1.91%
- Net Worth 8.47%
- Total Assets 9.66%
About Actavis Pharma Development Centre
Actavis Pharma Development Centre Private Limited (APDCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 August 2006 and has a history of 18 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 13.02 Cr.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹24.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Actavis Pharma Development Centre Private Limited India is Shweta as COMPANY SECRETARY. Sunilkumar Nagargoje, Vinod Shetty, and Nishank Bhargava serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2006PTC163981
-
Company No.
163981
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Aug 2006
-
Date of AGM
29 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Actavis Pharma Development Centre Private Limited offer?
Actavis Pharma Development Centre Private Limited offers a wide range of products and services, including Common Disease Medicines, Eye Care Medicines.
Who are the key members and board of directors at Actavis Pharma Development Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shweta | Company Secretary | 01-Jul-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunilkumar Nagargoje
|
Director | 27-Nov-2019 | Current |
|
Nishank Bhargava
|
Director | 23-Feb-2022 | Current |
|
Vinod Shetty
|
Director | 25-Aug-2021 | Current |
Financial Performance of Actavis Pharma Development Centre.
Actavis Pharma Development Centre Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.48% increase. The company also saw a substantial improvement in profitability, with a 36.54% increase in profit. The company's net worth moved up by a moderate rise of 8.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Actavis Pharma Development Centre?
In 2022, Actavis Pharma Development Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Watson Pharma Private LimitedNishank Bhargava is a mutual person
-
Teva India Private LimitedNishank Bhargava is a mutual person
-
Tevapharm India Private LimitedVinod Shetty and Nishank Bhargava are mutual person
-
Teva Pharmaceutical And Chemical Industries India Private LimitedVinod Shetty and Nishank Bhargava are mutual person
-
Teva Healthcare India Private LimitedVinod Shetty is a mutual person
-
Teva Global Business Services Private LimitedVinod Shetty and Nishank Bhargava are mutual person
Charges (Loans)
₹3.00 Cr
₹24.85 Cr
Charges Breakdown by Lending Institutions
- Jp Morgan Chase Bank, N.A. : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2017 | Jp Morgan Chase Bank, N.A. | ₹3.00 Cr | Open |
| 17 Jul 2010 | Idbi Bank Limited | ₹5.00 Cr | Satisfied |
| 26 Feb 2009 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.85 Cr | Satisfied |
| 25 Jul 2008 | Idbi Bank Ltd. | ₹14.00 Cr | Satisfied |
How Many Employees Work at Actavis Pharma Development Centre?
Actavis Pharma Development Centre has a workforce of 160 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Actavis Pharma Development Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actavis Pharma Development Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
